Form EFFECT ARCA biopharma, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 24, 2024 4:00 P.M. |
| Form: | S-4 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TowneBank Reports Second Quarter 2026 Earnings
- Crypto News Today: AlphaPepe Nears Tier-1 CEX Partnership Reveal as Ethereum Price Prediction Eyes $8,500
- PBCO Financial Corporation Reports Q2 2026 Results
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
